{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:09:43Z","timestamp":1760954983689},"reference-count":58,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.vaccine.2007.06.005","type":"journal-article","created":{"date-parts":[[2007,6,22]],"date-time":"2007-06-22T11:22:43Z","timestamp":1182511363000},"page":"6176-6190","source":"Crossref","is-referenced-by-count":65,"title":["Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune\u00ae vaccine"],"prefix":"10.1016","volume":"25","author":[{"given":"F.N.","family":"Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.P.","family":"Borja-Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Miyashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Grechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.B.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.B.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.A.","family":"Martins Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.R.","family":"Luvizotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Menz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Pess\u00f4a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.R.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Palatnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.B.","family":"Palatnik-de-Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.06.005_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4269\/ajtmh.1995.52.287","article-title":"Control of zoonotic visceral leishmaniasis. Is it time to change strategies?","volume":"52","author":"Tesh","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.06.005_bib2","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1086\/344312","article-title":"Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission","volume":"186","author":"Courtenay","year":"2002","journal-title":"J Inf Dis"},{"key":"10.1016\/j.vaccine.2007.06.005_bib3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1590\/S0001-37652004000300012","article-title":"Improving methods for epidemiological control of canine visceral leishmaniasis based on a mathematical model. Impact on the incidence of the canine and human disease. 2004","volume":"76","author":"Palatnik-de-Sousa","year":"2004","journal-title":"Ann Braz Acad Sci"},{"key":"10.1016\/j.vaccine.2007.06.005_bib4","unstructured":"MS-SINAN-Secretaria de Vigil\u00e2ncia em Sa\u00fade. Manual de Vigil\u00e2ncia e Controle da Leishmaniose Visceral. Editora MS. 2003. Bras\u00edlia-DF. pp.\u00a028."},{"key":"10.1016\/j.vaccine.2007.06.005_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/00034983.1994.11812879","article-title":"Canine leishmaniasis: Clinical, parasitological and entomological follow-up after chemotherapy","volume":"88","author":"Alvar","year":"1994","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.vaccine.2007.06.005_bib6","first-page":"339","article-title":"Le diagnostic pr\u00e9coce de la leishmaniose canine par la ponction ganglionnaire. R\u00e9flexions \u00e0 propos de soixante examens positifs obtenus en dix mois dans la r\u00e9gion Marseillaise","volume":"132","author":"Ranque","year":"1948","journal-title":"Bull Acad Nat Med"},{"key":"10.1016\/j.vaccine.2007.06.005_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1590\/S0074-02761985000300012","article-title":"Canine visceral leishmaniasis in Rio de Janeiro, Brazil. Clinical, Parasitological, Therapeutical and Epidemiological findings. (1977\u20131983)","volume":"80","author":"Marzochi","year":"1985","journal-title":"Mem Inst Osw Cruz"},{"key":"10.1016\/j.vaccine.2007.06.005_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/00034989860003","article-title":"Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis","volume":"92","author":"Oliva","year":"1998","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.vaccine.2007.06.005_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1051\/parasite\/1979543277","article-title":"\u00c9cologie des leishmanioses dans le sud de la France. 10. Les formes \u00e9volutives de la leishmaniose visc\u00e9rale canine. \u00c9laboration d\u2019une typologie bio-clinique \u00e0 finalit\u00e9 \u00e9pid\u00e9miologique","volume":"54","author":"Lanotte","year":"1979","journal-title":"Ann Parasitol"},{"key":"10.1016\/j.vaccine.2007.06.005_bib10","first-page":"40","article-title":"Zur leishmaniose des hundes. Infektionsverlauf, diagnose un therapieversuche nach exp. Infection vom Beagles mit Leishmania donovani (st. Kalkutta)","volume":"98","author":"Reiter","year":"1985","journal-title":"Berl M\u00fcnc Tier\u00e4rztl Wschr"},{"key":"10.1016\/j.vaccine.2007.06.005_bib11","unstructured":"Organiza\u00e7\u00e3o Mundial da Sa\u00fade. Lucha contra las leishmanioses. Serie de informes t\u00e9cnicos 1990; 793: 1\u2013177."},{"key":"10.1016\/j.vaccine.2007.06.005_bib12","doi-asserted-by":"crossref","unstructured":"Ikeda-Garc\u00eda F, Lopes RS, Marques FJ, Lima VMF, Morinishi CK, Bonnello FL et al. Clinical and Parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate. Vet parasitol 2006; (in press).","DOI":"10.1016\/j.vetpar.2006.08.019"},{"key":"10.1016\/j.vaccine.2007.06.005_bib13","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1590\/S0100-879X2005001200017","article-title":"Pharmacokinetic and parasitological evaluation of the bone marrow of dogs with visceral leishmaniasis submitted to multiple dose treatment with liposome-encapsulated meglumine antimoniate","volume":"38","author":"Schettini","year":"2005","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.vaccine.2007.06.005_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2915.1987.tb00364.x","article-title":"Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment","volume":"1","author":"Gradoni","year":"1987","journal-title":"Med Vet Entomol"},{"key":"10.1016\/j.vaccine.2007.06.005_bib15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4269\/ajtmh.2001.65.510","article-title":"Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil","volume":"65","author":"Palatnik-de-Sousa","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.06.005_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4269\/ajtmh.1996.55.125","article-title":"The logic of visceral leishmaniasis control","volume":"55","author":"Dye","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.06.005_bib17","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","article-title":"Autoclaved Leishmania major vaccine for prevention of leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan","volume":"356","author":"Khalil","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.06.005_bib18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1590\/S0074-02761996000600006","article-title":"Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs","volume":"91","author":"Mayrink","year":"1996","journal-title":"Mem Inst Osw Cruz MEMIOC"},{"key":"10.1016\/j.vaccine.2007.06.005_bib19","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA vaccine and vaccinia recombinant vectors expressing LACK","volume":"21","author":"Ramiro","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.005_bib20","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1016\/j.vaccine.2005.02.009","article-title":"Protective vaccination against canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and Type II of L. infantum","volume":"23","author":"Rafati","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.005_bib21","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1016\/j.vaccine.2005.05.011","article-title":"Leishmune\u00ae vaccine blocks the transmission of canine visceral leishmaniasis. Absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs","volume":"23","author":"Nogueira","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.005_bib22","unstructured":"Borja Cabrera GP, Santos FN, Paraguai de Souza E, Parra LM, Menz I, Xu Z et al. Phase I safety and immunogenicity trial of Leishmune\u00ae in dogs of Brazilian endemic areas. Third World Congress on Leishmaniasis, (Worldleish III), Palermo, Italy, 2005; pp.\u00a0116."},{"key":"10.1016\/j.vaccine.2007.06.005_bib23","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.vaccine.2004.01.072","article-title":"Protective vaccination against murine visceral leishmaniasis using aldehyde-containing Quillaja saponaria sapogenins","volume":"22","author":"Palatnik-de-Sousa","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.005_bib24","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1016\/j.vaccine.2006.02.034","article-title":"Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis","volume":"24","author":"Oliveira-Freitas","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.005_bib25","first-page":"290","article-title":"The FML vaccine (Fucose-Mannose Ligand) protects hamsters from experimental kala-azar","volume":"46","author":"Palatnik de Sousa","year":"1994","journal-title":"Ci\u00eancia e Cultura (J Braz Assoc Adv Sci)"},{"key":"10.1016\/j.vaccine.2007.06.005_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0264-410X(02)00444-9","article-title":"Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis","volume":"21","author":"Santos","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.005_bib27","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","article-title":"A Phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (S\u00e3o Gon\u00e7alo do Amarante, RN)","volume":"19","author":"da Silva","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.005_bib28","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S\u00e3o Gon\u00e7alo do Amarante)","volume":"20","author":"Borja-Cabrera","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.005_bib29","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.vaccine.2006.11.057","article-title":"Safety trial using the Leishmune\u00ae vaccine against canine visceral leishmaniasis in Brazil","volume":"25","author":"Parra","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.005_bib30","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.vaccine.2005.11.061","article-title":"The FML-vaccine (Leishmune\u00ae) against canine visceral leishmaniasis: a transmission blocking vaccine","volume":"24","author":"Saraiva","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.005_bib31","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/S0264-410X(00)00109-2","article-title":"Therapy of murine cutaneous leishmaniasis by DNA vaccination","volume":"18","author":"Handman","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.005_bib32","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1016\/j.vaccine.2006.03.005","article-title":"Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of L. donovani","volume":"24","author":"Gamboa-Le\u00f3n","year":"2006","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.vaccine.2007.06.005_bib33","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1016\/S0264-410X(03)00527-9","article-title":"Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine","volume":"21","author":"Santos","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.005_bib34","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2003.11.039","article-title":"Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine","volume":"22","author":"Borja-Cabrera","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.005_bib35","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1999.61.296","article-title":"The FML-ELISA assay in diagnosis and prognosis of canine visceral leishmaniasis","volume":"61","author":"Borja Cabrera","year":"1999","journal-title":"Am J Trop Med"},{"key":"10.1016\/j.vaccine.2007.06.005_bib36","first-page":"119","article-title":"Regulation of Leishmania population within the host. The variable course of Leishmania donovani infections in the mice","volume":"30","author":"Bradley","year":"1977","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2007.06.005_bib37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0195-5616(89)50083-4","article-title":"Cytology of cutaneous lesions","volume":"19","author":"Cowell","year":"1989","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.vaccine.2007.06.005_bib38","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0035-9203(95)90022-5","article-title":"Leishmania donovani: titration of antibodies to the Fucose-Mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis","volume":"89","author":"Palatnik de Sousa","year":"1995","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.06.005_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-4894(90)90031-7","article-title":"Amplification of kinetoplast DNA as a tool in the detection and diagnosis of Leishmania","volume":"71","author":"Rodgers","year":"1990","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2007.06.005_bib40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/rvsc.2000.0419","article-title":"Canine leishmaniasis transmission: higher infectivity among naturally infected dogs to sand flies is associated with lower proportions of T helper cells","volume":"69","author":"Guarga","year":"2000","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2007.06.005_bib41","unstructured":"UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases (TDR). Guidelines for the evaluation of Plasmodium falciparum vaccines in populations exposed to natural infections. TDR\/MAL\/VAC\/97. World Health organization, Geneva, Switzerland."},{"key":"10.1016\/j.vaccine.2007.06.005_bib42","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1128\/IAI.70.6.2763-2771.2002","article-title":"Mapping and sequencing of the canine NRAMP1 gene and identification of mutations in leishmaniasis-susceptible dogs","volume":"70","author":"Altet","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.06.005_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00251-003-0545-1","article-title":"Susceptibility to visceral leishmaniasis in the domestic dog is associated with MHC class II polymorphism","volume":"55","author":"Quinnell","year":"2003","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2007.06.005_bib44","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1128\/IAI.72.3.1240-1247.2004","article-title":"Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production","volume":"72","author":"Norsworthy","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.06.005_bib45","unstructured":"Borja-Cabrera GP. An\u00e1lise do potencial diagn\u00f3stico, progn\u00f3stico e imunoprotetor do ant\u00edgeno FML (Ligante de Fucose Manose) de Leishmania (L.) donovani,no calazar canino experimental e de \u00e1rea end\u00eamica. PhD Thesis. Department of Experimental Pathology. Federal Fluminense University. 2000. pp.\u00a079."},{"key":"10.1016\/j.vaccine.2007.06.005_bib46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1017\/S0031182097001200","article-title":"The epidemiology of canine leishmaniasis: transmission rates estimated from a cohort study in Amazonian Brazil","volume":"115","author":"Quinnell","year":"1997","journal-title":"Parasitol"},{"key":"10.1016\/j.vaccine.2007.06.005_bib47","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S1359-6446(03)02864-2","article-title":"Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity","volume":"8","author":"Marciani","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.vaccine.2007.06.005_bib48","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/S0264-410X(01)00031-7","article-title":"Vaccination of Balb\/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani","volume":"19","author":"Paraguai de Souza","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.005_bib49","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-3024.1995.tb00914.x","article-title":"Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites","volume":"17","author":"Deplazes","year":"1995","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2007.06.005_bib50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0304-4017(00)00446-5","article-title":"Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment","volume":"96","author":"Solano-Gallego","year":"2001","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2007.06.005_bib51","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/S0264-410X(03)00046-X","article-title":"IgG1\/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniasis","volume":"21\/19\u201320","author":"Mendes","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.005_bib52","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nm0202-166","article-title":"IL-4-secreting CD4+ T cells are crucial to the development of CD8+-cells responses against malaria liver stages","volume":"8","author":"Carvalho","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2007.06.005_bib53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4269\/ajtmh.2001.64.119","article-title":"Canine visceral leishmaniasis in Colombia: relationship between clinical and parasitologic status and infectivity for sand flies","volume":"64","author":"Travi","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.06.005_bib54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-2427(99)00096-3","article-title":"The immune response and PBMC subsets in canine visceral leishmaniasis before and after chemotherapy","volume":"30","author":"Moreno","year":"1999","journal-title":"Vet Immunopathol"},{"key":"10.1016\/j.vaccine.2007.06.005_bib55","first-page":"547","article-title":"Experimental murine Leishmania donovani infection: Immunoprotection by the Fucose-Mannose Ligand (FML)","volume":"27","author":"Palatnik de Sousa","year":"1994","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.vaccine.2007.06.005_bib56","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/S0264-410X(99)00058-4","article-title":"Vaccination with the FML antigen (Fucose-Mannose Ligand) of Leishmania donovani in the Swiss Albino model","volume":"17","author":"Santos","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.005_bib57","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/j.vaccine.2005.01.072","article-title":"A bivalent conjugate vaccine in the treatment of relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 or QS21","volume":"23","author":"Slovin","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.005_bib58","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-3024.1992.tb00469.x","article-title":"Vaccination of dogs against Babesia canis infection using parasite antigens from in vitro culture","volume":"14","author":"Schetters","year":"1992","journal-title":"Parasite Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07006810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07006810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T08:31:43Z","timestamp":1587630703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07006810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":58,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0264410X07006810"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.06.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}